All lobbying filings

VENABLE LLP

Lobbying for THE DIATRIBE FOUNDATION · Diabetes nonprofit

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; Policy related to the use of Continuous Glucose Monitors and access to insulin; Insulin Act (S. 4189 / H.R. 3014); Diabetes Act (S. 4037); Drug pricing/PBM Reform; Medicare Diabetes quality measures; Medicare coverage of diabetes - related devices/technology, drugs, and care.

Bills named in this filing 3

S. 4189
INSULIN Act of 2026
H.R. 3014
To amend title 38, United States Code, to expand the authority of the Secretary of Veterans Affairs to make grants to e…
S. 4037
Diabetes Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.